Prothena | PRTA - Revenu Net

Prix De L'Action
9.76
Variation Quotidienne
-0.10 -1.01%
Mensuellement
-7.22%
Annuel
35.93%
Q2 Prévisions
9.47




Revenu Net Changement Date
Acadia Pharmaceuticals USD 3.64M 269.93M 2026-03
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Akebia Therapeutics USD -12.24M 12.78M 2025-12
ALKERMES USD -66.48M 115.82M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amgen USD 1.82B 486M 2026-03
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Exelixis USD 210.47M 34.06M 2026-03
Immunic USD -19.3M 6.28M 2025-12
Incyte USD 303.33M 4.05M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
MacroGenics USD -14.16M 30.98M 2025-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Neurocrine Biosciences USD 197.9M 44.2M 2026-03
Prothena USD -21.59M 14.95M 2025-12
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03
Xoma USD -17.24M 33.23M 2024-09